Literature DB >> 23291856

Increased plasma resistin and decreased omentin levels in Japanese patients with psoriasis.

Hidetoshi Takahashi1, Hitomi Tsuji, Masaru Honma, Akemi Ishida-Yamamoto, Hajime Iizuka.   

Abstract

Psoriasis is associated with obesity accompanied by insulin resistance. A recent study disclosed increased plasma resistin and decreased plasma omentin levels in obesity. Few studies of plasma levels of resistin and omentin are available in psoriasis. We analyzed plasma levels of resistin and omentin in psoriasis and compared them with those of healthy controls. Evaluation of plasma levels of resistin and omentin was performed by enzyme-linked immunosorbent assay (ELISA) for 62 psoriasis patients and 58 healthy controls. The severity of psoriasis was evaluated by psoriasis area and severity index (PASI) score. Plasma levels of resistin were significantly increased in psoriasis as compared with those of healthy controls. In contrast, plasma levels of omentin were significantly decreased in psoriasis patients. Plasma levels of resistin and omentin were positively and negatively correlated with PASI scores, respectively. After the treatment of psoriasis, resistin levels were decreased and omentin levels were increased, respectively, compared with those of pretreated. Plasma levels of resistin and omentin might be useful for evaluating the disease activity of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23291856     DOI: 10.1007/s00403-012-1310-9

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  14 in total

Review 1.  Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations.

Authors:  Kerstin Wolk; Robert Sabat
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

2.  Interaction of Resistin and Systolic Blood Pressure in Psoriasis Severity.

Authors:  Divya Seth; Alexa N Ehlert; Jackelyn B Golden; Giovanni Damiani; Thomas S McCormick; Mark J Cameron; Kevin D Cooper
Journal:  J Invest Dermatol       Date:  2019-11-15       Impact factor: 8.551

3.  Decreased levels of vaspin and its potential association with cardiometabolic risk in patients with psoriasis: preliminary results.

Authors:  Paulina Kiluk; Anna Baran; Tomasz W Kaminski; Magdalena Maciaszek; Iwona Flisiak
Journal:  Postepy Dermatol Alergol       Date:  2021-02-07       Impact factor: 1.664

4.  Increased serum resistin levels correlate with psoriasis: a meta-analysis.

Authors:  Huiyun Huang; Erdong Shen; Shiqing Tang; Xingyou Tan; Xiuli Guo; Qiang Wang; Hongwei Ding
Journal:  Lipids Health Dis       Date:  2015-05-16       Impact factor: 3.876

5.  Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients.

Authors:  Simona Vachatova; Ctirad Andrys; Jan Krejsek; Miloslav Salavec; Karel Ettler; Vit Rehacek; Eva Cermakova; Andrea Malkova; Zdenek Fiala; Lenka Borska
Journal:  J Immunol Res       Date:  2016-12-21       Impact factor: 4.818

6.  Serum Omentin-1 in Psoriasis.

Authors:  Ola Ahmed Bakry; Shawky El Farargy; Naglaa Ghanayem; Somia Galal
Journal:  Indian J Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.494

7.  Association of Adipokines, Insulin Resistance, Hypertension and Dyslipidemia in Patients with Psoriasis Vulgaris.

Authors:  Melis Coban; Levent Tasli; Sebahat Turgut; Seyma Özkan; Melek Tunç Ata; Fulya Akın
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444

Review 8.  Current knowledge on psoriasis and autoimmune diseases.

Authors:  Nilmarie Ayala-Fontánez; David C Soler; Thomas S McCormick
Journal:  Psoriasis (Auckl)       Date:  2016-02-22

9.  Angiopoietin-like protein 2 in psoriasis: a new linkage with metabolic syndrome.

Authors:  Mohamed Zaki Kenawy; Jehan Hasan Sabry; Essam Mohamed Akl; Noha A H Emam
Journal:  Postepy Dermatol Alergol       Date:  2020-03-09       Impact factor: 1.837

Review 10.  New insights into different adipokines in linking the pathophysiology of obesity and psoriasis.

Authors:  Yi Kong; Suhan Zhang; Ruifang Wu; Xin Su; Daoquan Peng; Ming Zhao; Yuwen Su
Journal:  Lipids Health Dis       Date:  2019-09-14       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.